Anavex Life Sciences Corp (AVXL)

[powerwalker]

Bio, sokol and other Anavex/Biogen watchers:

To me, Biogen knows it is sitting on a 2-73 mother lode that will overthrow all other therapies in the CNS fields but doesn't know how to proceed.

I think Biogen has used 2-73 in combo with its MS drugs and in a MS mono-therapy with some of its human trial participants and is waiting to determine if its (2-73) efficacy fades over time. It won't!

It is the only explanation for the two year period of testing. No company at this stage of 2-73's development would spend TWO YEARS with petri dishes and mice trials! [Other than F1, most of us believe 2-73 is a safe drug.]

While TGD's price is high for Biogen on a partnership basis, once the public is made aware of previous unheard of benefits from 2-73 in MS treatment, the 10 figure price tag for a partnership will be understood by Biogen's s/holders ... unless Roche goes to 11 figures!


Anavex Now ... Mono-style!!!